VENTO, Sandro
 Distribuzione geografica
Continente #
NA - Nord America 3.959
EU - Europa 3.417
AS - Asia 2.447
SA - Sud America 537
AF - Africa 67
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.439
Nazione #
US - Stati Uniti d'America 3.890
RU - Federazione Russa 1.221
SG - Singapore 1.112
GB - Regno Unito 839
CN - Cina 627
BR - Brasile 451
VN - Vietnam 254
DE - Germania 211
SE - Svezia 203
FR - Francia 196
IE - Irlanda 192
IT - Italia 191
FI - Finlandia 187
HK - Hong Kong 185
KR - Corea 82
UA - Ucraina 66
CA - Canada 36
AR - Argentina 35
IN - India 31
ZA - Sudafrica 23
BD - Bangladesh 22
NL - Olanda 22
TR - Turchia 22
MX - Messico 19
ID - Indonesia 18
JP - Giappone 18
ES - Italia 17
BE - Belgio 16
NG - Nigeria 16
EC - Ecuador 14
PL - Polonia 13
CZ - Repubblica Ceca 12
CO - Colombia 11
IL - Israele 11
IQ - Iraq 9
SA - Arabia Saudita 9
AU - Australia 8
PK - Pakistan 8
CL - Cile 7
MA - Marocco 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
PY - Paraguay 6
AT - Austria 5
ET - Etiopia 5
LT - Lituania 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
NP - Nepal 4
AM - Armenia 3
DZ - Algeria 3
GR - Grecia 3
KG - Kirghizistan 3
NO - Norvegia 3
PA - Panama 3
PH - Filippine 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CH - Svizzera 2
EU - Europa 2
HR - Croazia 2
JM - Giamaica 2
LV - Lettonia 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
PS - Palestinian Territory 1
RE - Reunion 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
TW - Taiwan 1
Totale 10.439
Città #
Southend 726
Singapore 621
Jacksonville 602
Woodbridge 459
Chandler 380
Moscow 363
San Jose 339
Ashburn 263
Ann Arbor 198
Dublin 192
Dallas 187
Hong Kong 182
The Dalles 108
Houston 104
Verona 93
Beijing 87
Council Bluffs 83
Lawrence 77
Princeton 77
Ho Chi Minh City 74
Wilmington 72
Hanoi 64
Nanjing 63
New York 61
Los Angeles 58
Jinan 46
Shenyang 45
São Paulo 38
Buffalo 32
Santa Clara 31
Helsinki 29
Hebei 28
Munich 25
Nanchang 24
Changsha 23
Frankfurt am Main 23
Milan 23
Sindelfingen 23
Tianjin 23
Turku 22
Redondo Beach 21
Jiaxing 19
Denver 17
Ningbo 17
Seattle 17
Toronto 17
San Francisco 16
Brussels 15
Haikou 15
Haiphong 15
London 15
Orem 15
Tokyo 15
Abuja 14
Atlanta 14
Zhengzhou 14
Norwalk 13
Rio de Janeiro 13
Amsterdam 12
Bologna 12
Hangzhou 12
Taizhou 12
Warsaw 12
Belo Horizonte 11
Boardman 11
Brooklyn 11
Guangzhou 11
Lanzhou 11
Montreal 11
Brno 10
Johannesburg 10
Taiyuan 10
Chennai 9
Curitiba 9
Fairfield 9
Phoenix 9
Porto Alegre 9
Biên Hòa 8
Chicago 8
Da Nang 8
Poplar 8
Stockholm 8
Boston 7
Redmond 7
Tashkent 7
Thái Nguyên 7
Columbus 6
Fuzhou 6
Limeira 6
Madrid 6
Mumbai 6
Philadelphia 6
Quito 6
Redwood City 6
Salvador 6
Santo André 6
Seoul 6
Addis Ababa 5
Baghdad 5
Can Tho 5
Totale 6.600
Nome #
Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data 204
Aetiology of pneumonia following isolated closed head injury 200
Comparative evaluation of naturally occurring Pneumocystis carinii pneumonia (PCP) and PCP despite primary chemoprophylaxis in patients with AIDS 193
A case of visceral leishmaniasis with protracted incubation in a nonendemic area. 187
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 186
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 179
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 176
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 173
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 172
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 172
Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance 171
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 169
Cryptococcal meningitis during cyclosporin treatment in a patient with psoriasis. 167
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 165
Can we really identify HIV-1 long-term nonprogressors? 164
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 163
Clinical picture: Ring calcification in the chest X-ray of a 17-year-old girl: coronary aneurism following Kawasaki disease 162
Does tenofovir increase efavirenz hepatotoxicity? 161
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 161
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 160
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 156
Adherence to HAART in HIV. 153
Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy. 151
Diagnosis, management and outcome of clinically-suspected spinal infection 149
Autoimmune hepatitis type 1 after measles 148
Mortality due to hepatitis C virus-related cirrhosis in patients infected with HIV type 1: a role for alcohol 146
Early detection of lung cancer in high-risk patients with HIV-1 infection. 145
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 145
Hepatitis A virus infection and atherosclerosis 140
Failure of prophylaxis against PCP in patients with HIV infection 138
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature 138
Hyperacute unilateral gonococcal endophthalmitis in an HIV-infected man without genital infection 138
[CD4+ guided interruption HAART in HIV patients] 136
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 135
Early detection of lung cancer in high-risk patients with HIV-1 infection. 133
Microsporidium species in pulmonary cavitary lesions of AIDS patients infected with Rhodococcus equi 131
Tuberculosis among refugees and displaced people at the Burundi-Rwanda border 131
Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes. 130
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 130
Effect of pregnancy on chronic hepatitis C 130
Syphilis in prostitutes from Eastern Europe. 129
Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C 128
Initial hospitalization and adherence to highly active antiretroviral therapy. 128
Inflammatory pseudotumor of lymph nodes. 127
Nosocomial Candidemia in non-neutropenic patients at an Italian tertiary care hospital 124
The PraSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria 124
Highly active antiretroviral therapy. 123
mIRTAZAPINE IN AN HIV-INFECTED PATIENT WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 123
Multdrug-resistant tuberculosis 122
Successful treatment of Castleman’s disease with HAART in two HIV-infected patients 121
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 121
Painful neuropathy vasculitis in 2 patients with long-standing human immunodeficiency virus-1 infection. 121
Unusual, rapidly growing ulcerative genital mass due to herpes simplex virus in a human immunodeficiency virus-infected woman. 119
M. tuberculosis drug resistance in AIDS 119
Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands 116
Infection with hepatitis G virus in immunoglobulin recipients 115
Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B. 114
Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. 113
Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. 111
MHC class I molecules and progression to AIDS 110
Human immunodeficiency virus-associated peripheral neuropathies 110
Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus 109
Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals 109
Fluconazole penetration into the prostatic fluid of patients with AIDS-associated cryptococcal meningitis. 107
HIV-1 progression in hepatitis-C- infected drug users 106
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 106
Selective drug taking during combination antiretroviral therapy. 104
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 104
Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy. 103
Highly active antiretroviral therapy. 101
Esophageal cryptococcosis in a patient with AIDS. 100
Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis. 100
Resolution of autoimmune hepatitis after bone-marrow transplantation 98
Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. 97
No increase in liver decompensation risk with atypical hepatitis C virus antibody pattern. 97
Isolated Presence of Antibody to Hepatitis B core antigen in injection drug users: do they need to be vaccinated? 90
Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection. 88
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 85
Totale 10.510
Categoria #
all - tutte 35.991
article - articoli 35.991
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.982


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/2022640 47 200 7 27 13 20 12 37 29 29 53 166
2022/20231.179 84 113 121 169 139 275 5 76 150 7 25 15
2023/2024406 27 36 44 44 69 51 5 9 2 9 52 58
2024/20251.385 106 83 26 222 60 24 69 37 254 92 93 319
2025/20264.016 293 264 264 760 1.023 252 321 201 349 146 46 97
Totale 10.510